The NOL9 antibody is a research tool designed to detect and study the NOL9 protein, a nucleolar enzyme implicated in ribosomal RNA (rRNA) processing and ribosome biogenesis. NOL9 (nucleolar protein 9) is a conserved eukaryotic protein with endonuclease and exonuclease activities, critical for cleaving and maturing precursor rRNA molecules. It interacts with components of the small subunit (SSU) processome, a large ribonucleoprotein complex essential for 18S rRNA synthesis. Dysregulation of NOL9 has been linked to genomic instability, developmental disorders, and cancer progression due to its role in maintaining ribosomal homeostasis and cell proliferation.
The NOL9 antibody is primarily used in molecular biology and cancer research to investigate NOL9 expression, localization, and function. It enables techniques like Western blotting, immunofluorescence, and immunohistochemistry to visualize NOL9's nucleolar distribution and assess its levels in normal versus diseased tissues. Studies utilizing this antibody have highlighted elevated NOL9 expression in certain cancers, suggesting its potential as a diagnostic or prognostic biomarker. Furthermore, it aids in exploring NOL9's interplay with other ribosome assembly factors and its regulatory mechanisms under stress conditions.
Developed in various host species (e.g., rabbit, mouse), NOL9 antibodies are validated for specificity and sensitivity, supporting diverse experimental applications to unravel ribosomopathies and cancer biology pathways.